Strategy

Mar 05, 2008
Pharmaceutical Executive
By Pharmaceutical Executive Editors
A review of a pilot ePrescribing program reveals that if physicians are given the proper support, the technology can increase safer prescribing habits and boost compliance.
Mar 03, 2008
Successful Product Manager's Handbook
What will it take for pharma to move away from seat-of-your-pants training for product managers?
Mar 03, 2008
Successful Product Manager's Handbook
A look at what Allergan is doing to take on spotty product manager training
Mar 03, 2008
Successful Product Manager's Handbook
A PMO can help drive a new-product launch to goal
Mar 01, 2008
Pharmaceutical Executive
By Pharmaceutical Executive Editors
Roche has always gone its own way with biologics, deals, and new medicines. Now that the rest of industry has caught on, how can Roche stay ahead of its time?
Mar 01, 2008
Pharmaceutical Executive
Pharma gets less ink as news reporters shift their sights to other topics? That's a good thing--Isn't it?
Feb 20, 2008
Pharmaceutical Executive
By Pharmaceutical Executive Editors
Baxter blood thinner has been put on ice while the Feds examine the huge increase in adverse reactions.
Feb 20, 2008
Pharmaceutical Executive
By Pharmaceutical Executive Editors
A new study shows that while doctors aren't in a rush to stop prescribing Vytorin, they are considering it less often as a first-line treatment option.
Feb 06, 2008
Pharmaceutical Executive
By Pharmaceutical Executive Editors
Pfizer boosted warnings and prescribing information on its smoking-cessation drug Chantix in response to an early safety review by FDA. Side effects such as depression, suicidal thoughts, and odder-than-normal dreams have been attributed to use of the drug.
Feb 01, 2008
Pharmaceutical Executive
By Pharmaceutical Executive Editors
US officials think they can control MRSA and other "superbugs," but dangerous bacteria know no boundaries. What does the world do when its drugs stop working?
native1_300x100
lorem ipsum